搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Business Insider
1 天
Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides ...
CDK2 and Cyclin ... degradation, and key downstream pharmacodynamic markers including CD69, IL-2, IL-6, and IL-17. Submit an IND application for MRT-8102 in H1 2025. Nominate a CDK2 program ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
3 charged in Payne's death
Biden addresses nation
Fed cuts interest rates
Trump picks chief of staff
Election appeal rejected
Immigration policy blocked
Canada shuts down offices
43 monkeys escape SC lab
Time to get flu, COVID shots
AU plans social media ban
Southern California wildfire
Project Veritas suit revived
Pledges 'orderly' transition
Hurricane Rafael tracker
Assigned to G-League
Jury deliberations begin
WI school shooting thwarted
Mortgage rates rise again
Proposes decongestant ban
Salisbury hate crime charges
US probes racist texts
Fired by Philadelphia Union
New Pompeii DNA evidence
Ellison begins 2-yr sentence
Wins in Pennsylvania
Israel to evacuate citizens
Expands bird flu testing
Flips PA Senate seat
Newsom calls special session
反馈